Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:54 PM
Ignite Modification Date:
2025-12-24 @ 9:54 PM
NCT ID:
NCT00462332
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of chronic lymphocytic leukemia (CLL)
* Advanced or progressive disease with ≥ 2 active clinical signs
PATIENT CHARACTERISTICS:
* Fertile patients must use adequate contraception
* No positive Coomb's test with signs of hemolysis
* No active infection
* No uncontrolled severe disease
* No known hypersensitivity or anaphylactic reactions to murine antibodies or proteins
* No other malignancies within the past 2 years except for adequately treated malignancies
* No significant traumatic injury within the past 4 weeks
* No coexisting medical or psychological condition that would limit study compliance
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No prior treatment for CLL
* No major surgery within the past 4 weeks
* No prior chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
60 Years
Study:
NCT00462332
Study Brief:
Protocol Section:
NCT00462332